Skip to content

Public FDA record

Z-0359-2027: LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303

Recall record Z-0359-2027 for Luminex Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0359-2027
Company in FDA record
Luminex Corporation
FDA classification date
Nov 5, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.

Source facts

Action
On October 5, 2026, the firm began notifying customers via "Urgent Field Safety Notice - Medical Device Recall" letters. Consignees were informed that the current Instructions for Use for the Gram-Negative Blood Culture Assay do not adequately describe interpretation of certain positive family-level results. Specifically, when a positive family-level only result is obtained ("family-level only result" refers to a positive organism family-level detection without an accompanying genus- or species-level identification), repeat testing with the LIAISON PLEX Gram-Negative Blood Culture Assay is recommended. Absence of this instruction may increase the likelihood that certain reportable detections are not appropriately recognized by the user and may contribute to an incorrect interpretation of test results. Customers were instructed to implement the following interpretation guidance: When a positive family-level only result is obtained, repeat testing with the LIAISON PLEX BCN assay is recommended. DiaSorin is updating the Instructions for Use to include the revised guidance. Revised labeling will be provided following implementation of the labeling revision. Please contact Technical Support Services with any questions or concerns at the following phone numbers:1-877-785-2323 (U.S. and Canada); +1-512-381-4397 (Outside U.S. and Canada); 1-512-219-5114 (Fax) and email:support@luminexcorp.com.
Initiated
2026-10-05
Root cause
Error in labeling
Distribution
US distribution nationwide. No OUS distribution.
Recall number
Z-0359-2027
Recall status
Open, Classified
CDRH record ID
223172
FDA classified
2026-11-05
Recall event number
100036

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗